Animal Health Archives
Animal Pharmaceuticals
06/22/2026
Continuous Data Isn’t Optional for Animal Health
Animal health teams are moving more temperature-sensitive materials through more complex distribution networks than ever before. Vaccines, biotherapeutics, reproductive materials, diagnostics, and advanced therapies are all crossing longer distances and passing through more handoffs to reach a wider mix of farms, clinics, production facilities, and research sites. As that complexity grows, the standard for what logistics data must show is also changing. Programs are increasingly expected to document the actual condition and custody of materials throughout transit rather than rely on fragmented records assembled after delivery.
Animal Pharmaceuticals
10/21/2025
Quality Assurance in Animal Health Supply Chains: How to Mitigate Risks
In the animal health industry, innovation doesn’t end when a new therapy leaves the lab. From the moment a product is ready to move, its quality depends on one thing above all else: a controlled, reliable supply chain. In this context, quality assurance (QA) goes beyond a regulatory requirement and quickly becomes a critical safeguard that ensures every shipment maintains its efficacy and compliance throughout the complexities of transport.
Managing the Cold Chain
10/15/2025
The Connected Chain: Why Supply Chain Integration Matters in Advanced Therapy Manufacturing
Contract Development and Manufacturing Organizations (CDMOs) are at the heart of the advanced therapy ecosystem, managing complex, high-stakes programs that demand speed and compliance. As therapies move from early development into clinical trials and through to commercialization, every stage of manufacturing, packaging, biostorage, and final drug delivery need to align perfectly for seamless execution. Yet in many cases, these functions are managed by multiple vendors, each operating in isolation. The result is a fragmented supply chain that increases risk while slowing execution due to layers of operational burden.
Animal Pharmaceuticals
09/23/2025
Revolutionizing Animal Health Logistics: How Advanced Technology Protects Product Quality
Innovation in the animal health sector extends far beyond the laboratory. While researchers develop next-generation vaccines, advanced biologics, and complex veterinary therapeutics, the logistics that bring these products from manufacturing to the field are evolving just as rapidly. For companies delivering temperature-sensitive products across continents, ensuring quality has quickly become mission-critical. A shipment that arrives late, compromised, or out of specification can affect patient outcomes and regulatory compliance, all while quietly eroding operational efficiency and profit margins.
Managing the Cold Chain
08/01/2025
Built for Speed: How Cryoport Systems Delivers Without Compromise
In the life sciences, time isn’t just money, it impacts patient outcomes, regulatory compliance, and even trial integrity. When a temperature-sensitive shipment is delayed due to inventory shipper shortages or logistical bottlenecks, the impact can cascade across an entire program. Unfortunately, these scenarios aren’t theoretical. When you’re working with irreplaceable biologic materials, this kind of disruption quickly moves from inconvenient to unacceptable.
Animal Pharmaceuticals
06/17/2025
Ensuring Safe, On-Time Deliveries for Animal Biopharma
Transporting advanced therapeutics for the animal health industry is just as time- and temperature-sensitive as human therapeutics, yet it is not often managed with the same level of care. This results in biologics and vaccines running into preventable risk during transit. Whether you’re supporting a clinical trial, delivering commercial supply, or responding to a health emergency, ensuring the quality, compliance, and visibility of every shipment is crucial.
Animal Pharmaceuticals
04/16/2025
Delivering Over 5 Billion Doses of Biotherapeutics to Protect Animal Health Worldwide
In 2024, Cryoport Systems achieved a remarkable milestone: the delivery of over 5 billion doses of biotherapeutics, including cell-based therapies, antibody-based therapies, and vaccines to the global animal health industry. This achievement is the result of our unwavering commitment to ensuring the health and well-being of animals across the world, from livestock that sustain global food supply chains to the beloved companion animals that enrich our lives.
Navigating Logistics
03/24/2025
Strengthening Global ATMP Logistics: How Cryoport Systems’ Netherlands Facility Supports Temperature-Controlled Supply Chains
The success of ATMPs depends on more than just scientific breakthroughs, it requires a highly controlled, risk-mitigated supply chain that ensures product integrity from research through commercialization. With cell and gene therapies moving across multiple clinical sites, manufacturing facilities, and regulatory jurisdictions, developers need a logistics partner that can support seamless, temperature-controlled supply chain management at a global scale.
Navigating Logistics
03/12/2025
The Gateway to Europe: How Cryoport Systems’ Stevenage Supply Chain Hub Supports ATMP Development
For UK-based Advanced Therapy Medicinal Product (ATMP) developers, access to European clinical trial sites and commercial markets is a critical component of a successful growth strategy. Yet, navigating regulatory barriers, customs challenges, and supply chain complexities can create unnecessary delays, increase costs, and put the integrity of sensitive biologics at risk.Categories
- All (51)
- Animal Pharmaceuticals (23)
- Expert Insights (12)
- Livestock Management (10)
- Veterinary Support (14)